- Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia
- Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia
- Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia.
